(MedPage Today) — SAN FRANCISCO — Research presented at the annual Crohn’s and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each biologic against Janus kinase (JAK…
Source link : https://www.medpagetoday.com/meetingcoverage/ccc/114186
Author :
Publish date : 2025-02-12 15:45:58
Copyright for syndicated content belongs to the linked Source.
